
News|Slideshows|October 12, 2022
Cardiometabolic Disease Update: 12 Studies
Studies of cardiometabolic disease pathophysiology, prevention, and treatment make science news every day. Find 12 here, at-a-glance.
Advertisement
Less than 7% of the US population has optimal cardiometabolic health according to a novel study that assessed 5 key components of the measure. That disappointing metric and others like it have fueled a surge in research into cardiometabolic disease pathophysiology, prevention, and treatment.
Click through the 12 slides in this update for an at-a-glance overview of 2022's most promising cardiometabolic research to date.
CKD, Heart Failure, Hypertension, MACE, NAFLD/NASH, Type 2 Diabetes
Newsletter
Enhance your clinical practice with the Patient Care newsletter, offering the latest evidence-based guidelines, diagnostic insights, and treatment strategies for primary care physicians.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Patient Care Online
1
Merck Secures Fast Track for Novel AD Antibody and Reports First-in-Human Data
2
Baxdrostat Granted FDA Priority Review for Hard-to-Control Hypertension, Could Be First-In-Class Therapy
3
Obesity Linked to Faster Alzheimer Disease Progression in Longitudinal Blood Biomarker Analysis
4
WHO Issues First Guidelines on GLP-1 Receptor Agonists for Obesity Treatment
5

















































































































































































































































































